These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
222 related articles for article (PubMed ID: 26670086)
1. Nonaspirin Nonsteroidal Anti-Inflammatory Drugs and Risk of Hemorrhagic Stroke: A Systematic Review and Meta-Analysis of Observational Studies. Ungprasert P; Matteson EL; Thongprayoon C Stroke; 2016 Feb; 47(2):356-64. PubMed ID: 26670086 [TBL] [Abstract][Full Text] [Related]
2. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: A systematic review and meta-analysis of observational studies. Ungprasert P; Cheungpasitporn W; Crowson CS; Matteson EL Eur J Intern Med; 2015 May; 26(4):285-91. PubMed ID: 25862494 [TBL] [Abstract][Full Text] [Related]
3. Risk of Hemorrhagic Stroke in Patients Exposed to Nonsteroidal Anti-Inflammatory Drugs: A Meta-Analysis of Observational Studies. Islam MM; Poly TN; Walther BA; Yang HC; Lin MC; Li YC Neuroepidemiology; 2018; 51(3-4):166-176. PubMed ID: 30153662 [TBL] [Abstract][Full Text] [Related]
4. Non-steroidal anti-inflammatory drugs and risk of heart failure exacerbation: A systematic review and meta-analysis. Ungprasert P; Srivali N; Kittanamongkolchai W Eur J Intern Med; 2015 Nov; 26(9):685-90. PubMed ID: 26427540 [TBL] [Abstract][Full Text] [Related]
5. Risk of death or reinfarction associated with the use of selective cyclooxygenase-2 inhibitors and nonselective nonsteroidal antiinflammatory drugs after acute myocardial infarction. Gislason GH; Jacobsen S; Rasmussen JN; Rasmussen S; Buch P; Friberg J; Schramm TK; Abildstrom SZ; Køber L; Madsen M; Torp-Pedersen C Circulation; 2006 Jun; 113(25):2906-13. PubMed ID: 16785336 [TBL] [Abstract][Full Text] [Related]
6. Nonsteroidal Anti-inflammatory Drugs and Risk of Incident Heart Failure: A Systematic Review and Meta-analysis of Observational Studies. Ungprasert P; Srivali N; Thongprayoon C Clin Cardiol; 2016 Feb; 39(2):111-8. PubMed ID: 26720629 [TBL] [Abstract][Full Text] [Related]
7. Use of nonsteroidal anti-inflammatory drugs among healthy people and specific cerebrovascular safety. Fosbøl EL; Olsen AM; Olesen JB; Andersson C; Kober L; Torp-Pedersen C; Gislason GH Int J Stroke; 2014 Oct; 9(7):943-5. PubMed ID: 23088217 [TBL] [Abstract][Full Text] [Related]
8. Non-steroidal antiinflammatory drugs and the risk of acute myocardial infarction. Hernández-Díaz S; Varas-Lorenzo C; García Rodríguez LA Basic Clin Pharmacol Toxicol; 2006 Mar; 98(3):266-74. PubMed ID: 16611201 [TBL] [Abstract][Full Text] [Related]
10. Use of non-steroidal anti-inflammatory drugs correlates with the risk of venous thromboembolism in knee osteoarthritis patients: a UK population-based case-control study. Lee T; Lu N; Felson DT; Choi HK; Dalal DS; Zhang Y; Dubreuil M Rheumatology (Oxford); 2016 Jun; 55(6):1099-105. PubMed ID: 26983451 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular safety of lumiracoxib: a meta-analysis of all randomized controlled trials > or =1 week and up to 1 year in duration of patients with osteoarthritis and rheumatoid arthritis. Matchaba P; Gitton X; Krammer G; Ehrsam E; Sloan VS; Olson M; Mellein B; Hoexter G; Orloff J; Garaud JJ Clin Ther; 2005 Aug; 27(8):1196-214. PubMed ID: 16199245 [TBL] [Abstract][Full Text] [Related]
12. Stroke risk and NSAIDs: a systematic review of observational studies. Varas-Lorenzo C; Riera-Guardia N; Calingaert B; Castellsague J; Pariente A; Scotti L; Sturkenboom M; Perez-Gutthann S Pharmacoepidemiol Drug Saf; 2011 Dec; 20(12):1225-36. PubMed ID: 21971833 [TBL] [Abstract][Full Text] [Related]
13. Cardiovascular events associated with long-term use of celecoxib, rofecoxib and meloxicam in Taiwan: an observational study. Huang WF; Hsiao FY; Tsai YW; Wen YW; Shih YT Drug Saf; 2006; 29(3):261-72. PubMed ID: 16524325 [TBL] [Abstract][Full Text] [Related]
14. Association between nonnaproxen NSAIDs, COX-2 inhibitors and hospitalization for acute myocardial infarction among the elderly: a retrospective cohort study. Rahme E; Watson DJ; Kong SX; Toubouti Y; LeLorier J Pharmacoepidemiol Drug Saf; 2007 May; 16(5):493-503. PubMed ID: 17086567 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2. McGettigan P; Henry D JAMA; 2006 Oct; 296(13):1633-44. PubMed ID: 16968831 [TBL] [Abstract][Full Text] [Related]
16. Myocardial infarction and individual nonsteroidal anti-inflammatory drugs meta-analysis of observational studies. Varas-Lorenzo C; Riera-Guardia N; Calingaert B; Castellsague J; Salvo F; Nicotra F; Sturkenboom M; Perez-Gutthann S Pharmacoepidemiol Drug Saf; 2013 Jun; 22(6):559-70. PubMed ID: 23616423 [TBL] [Abstract][Full Text] [Related]
17. Cardiovascular Risk of Nonsteroidal Anti-inflammatory Drugs and Classical and Selective Cyclooxygenase-2 Inhibitors: A Meta-analysis of Observational Studies. Martín Arias LH; Martín González A; Sanz Fadrique R; Vazquez ES J Clin Pharmacol; 2019 Jan; 59(1):55-73. PubMed ID: 30204233 [TBL] [Abstract][Full Text] [Related]
18. Nonsteroidal anti-inflammatory drugs for perioperative pain control. Burgess FW; Browning RA Med Health R I; 2001 Oct; 84(10):327-8. PubMed ID: 11693050 [No Abstract] [Full Text] [Related]
19. Individual NSAIDs and upper gastrointestinal complications: a systematic review and meta-analysis of observational studies (the SOS project). Castellsague J; Riera-Guardia N; Calingaert B; Varas-Lorenzo C; Fourrier-Reglat A; Nicotra F; Sturkenboom M; Perez-Gutthann S; Drug Saf; 2012 Dec; 35(12):1127-46. PubMed ID: 23137151 [TBL] [Abstract][Full Text] [Related]
20. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Johnsen SP; Larsson H; Tarone RE; McLaughlin JK; Nørgård B; Friis S; Sørensen HT Arch Intern Med; 2005 May; 165(9):978-84. PubMed ID: 15883235 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]